Victory Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Victory Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.23M	Buy	20,394 +1,079	+6%	+$146K	﹤0.01%	1497
2026 Q1	$2.47M	Hold	19,315	–	–	﹤0.01%	1544
2025 Q4	$2.36M	Buy	19,315 +2,066	+12%	+$237K	﹤0.01%	1541
2025 Q3	$1.73M	Hold	17,249	–	–	﹤0.01%	1638
2025 Q2	$1.43M	Buy	+17,249	New	+$1.38M	﹤0.01%	1691
2022 Q3	–	Sell	-64,991	Closed	-$4.83M	–	2782
2022 Q2	$4.83M	Buy	+64,991	New	+$4.88M	0.01%	1255
2015 Q4	–	Sell	-52,910	Closed	-$3.29M	–	1695
2015 Q3	$3.29M	Sell	52,910 -19,759	-27%	-$1.56M	0.01%	583
2015 Q2	$6.11M	Sell	72,669 -21,261	-23%	-$1.65M	0.02%	548
2015 Q1	$7.06M	Sell	93,930 -3,390	-3%	-$237K	0.03%	513
2014 Q4	$6.05M	Buy	+97,320	New	+$5.55M	0.02%	526
2014 Q2	–	Sell	-40,425	Closed	-$1.92M	–	926
2014 Q1	$1.92M	Sell	40,425 -2,700	-6%	-$138K	0.01%	428
2013 Q4	$1.87M	Buy	43,125 +975	+2%	+$40.4K	0.01%	442
2013 Q3	$1.81M	Buy	+42,150	New	+$1.71M	0.01%	432

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Victory Capital Management's XBI Position: Q2 2026 in Review

Victory Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 5.6% in Q2 2026, buying an estimated $146K and bringing the position to 20,394 shares worth $3.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

Victory Capital Management first reported a position in XBI in Q3 2013 and has held it in 13 quarters since. The position peaked at $7.06M in Q1 2015. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Victory Capital Management held 20,394 shares of State Street SPDR S&P Biotech ETF worth $3.23M as of Q2 2026.
Victory Capital Management bought 1,079 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $146K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1497 holding.
Victory Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and has held it in 13 quarters since.
Victory Capital Management's State Street SPDR S&P Biotech ETF position peaked at $7.06M in Q1 2015.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.